Atlas Trials

Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability of Tigecycline in Patients 8 to 11 Years of Age

Clinical trial NCT00488345 · COMPLETED

Trial details

NCT number
NCT00488345
Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Bacterial InfectionsIntra-Abdominal InfectionPneumonia, BacterialSkin Diseases, BacterialSkin Diseases, Infectious
Start date
2007-12-01
Primary completion
2009-09-01
Enrollment
59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.